The neurodevelopmental model of schizophrenia: update 2005
The DOI matches its Crossref record; 180 of the 180 references it cites were found in a registry or an index.
Abstract
Neurodevelopmental models of schizophrenia that identify longitudinal precursors of illness have been of great heuristic importance focusing most etiologic research over the past two decades. These models have varied considerably with respect to specificity and timing of hypothesized genetic and environmental 'hits', but have largely focused on insults to prenatal brain development. With heritability around 80%, nongenetic factors impairing development must also be part of the model, and any model must also account for the wide range of age of onset. In recent years, longitudinal brain imaging studies of both early and adult (to distinguish from late ie elderly) onset populations indicate that progressive brain changes are more dynamic than previously thought, with gray matter volume loss particularly striking in adolescence and appearing to be an exaggeration of the normal developmental pattern. This supports an extended time period of abnormal neurodevelopment in schizophrenia in addition to earlier 'lesions'. Many subtle cognitive, motor, and behavioral deviations are seen years before illness onset, and these are more prominent in early onset cases. Moreover, schizophrenia susceptibility genes and chromosomal abnormalities, particularly as examined for early onset populations (ie GAD1, 22q11DS), are associated with premorbid neurodevelopmental abnormalities. Several candidate genes for schizophrenia (eg dysbindin) are associated with lower cognitive abilities in both schizophrenic and other pediatric populations more generally. Postmortem human brain and developmental animal studies document multiple and diverse effects of developmental genes (including schizophrenia susceptibility genes), at sequential stages of brain development. These may underlie the broad array of premorbid cognitive and behavioral abnormalities seen in schizophrenia, and neurodevelopmental disorders more generally. Increased specificity for the most relevant environmental risk factors such as exposure to prenatal infection, and their interaction with susceptibility genes and/or action through phase-specific altered gene expression now both strengthen and modify the neurodevelopmental theory of schizophrenia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, the association of pervasive developmental disorders (PDD) and psychosis is in consonance with the finding, from the NIMH very early-onset SZ sample, of a history of PDD (as per DSM-III) in roughly a third of the patients with SZ. 55”
From Developmental Differences Between Schizophrenia and Bipolar Disorder (2017) · cites this paper as [55]
Citations
Cites
Epigenetic programming by maternal behavior
Weaver, I. C. G., Cervoni, N., Champagne, F. A., D'Alessio, A. C., Sharma, S., Seckl, J. R., Dymov, S., Szyf, M., & Meaney, M. J. (2004) · Nature Neuroscience · doi:10.1038/nn1276 · Cited by 6,177
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
Weinberger, D. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800190080012 · Cited by 3,724
Large-scale copy number polymorphism in the human genome
Sebat, J., Lakshmi, B., Troge, J., Alexander, J., Young, J., Lundin, P., Månér, S., Massa, H., Walker, M., Chi, M., et al. (2004) · Science · doi:10.1126/science.1098918 · Cited by 2,557
A review of MRI findings in schizophrenia
Shenton, M. E., Dickey, C. C., Frumin, M., & McCarley, R. W. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00163-3 · Cited by 2,346
Pinkel, D., Segraves, R., Sudar, D., Clark, S., Poole, I., Kowbel, D., Collins, C., Kuo, W.-L., Chen, C., Zhai, Y., et al. (1998) · Nature Genetics · doi:10.1038/2524 · Cited by 2,240
Kim-Cohen, J., Caspi, A., Moffitt, T. E., Harrington, H., Milne, B. J., & Poulton, R. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.7.709 · Cited by 2,025
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
Neuregulin 1 and Susceptibility to Schizophrenia
Stefansson, H., Petursson, H., Sigurdsson, E., Steinthorsdottir, V., Bjornsdottir, S., Sigmundsson, T., Ghosh, S., Brynjolfsson, J., Gunnarsdottir, S., Ivarsson, O., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342734 · Cited by 1,683
The neuropathology of schizophrenia
Harrison, P. J. (1999) · Brain · doi:10.1093/brain/122.4.593 · Cited by 1,677
Meta-analysis of regional brain volumes in schizophrenia
Wright, I. C., Rabe-Hesketh, S., Woodruff, P. W. R., David, A. S., Murray, R. M., & Bullmore, E. T. (2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.16 · Cited by 1,662
Research works printed but not linked: 1
- Straub RE, Straub RE, Lipska BK, Egan MF, Goldberg TE, Callicott JH et al. GAD1, which encodes glutamate decarbozylase 1 (GAD 67), is associated with adult onset schizophrenia in two independent samples. Am J Med Genet 2003; 122B: 177.
Cited by
Items 101–200 of 1,000
Development of social functioning in preschizophrenia children and adolescents: A systematic review.
Tarbox, S. I., & Pogue-Geile, M. F. (2008) · Psychological Bulletin · doi:10.1037/0033-2909.34.4.561 · Cited by 142
Anderson, G., & Maes, M. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.06.014 · Cited by 146
Ghiani, C. A., Starcevic, M., Rodriguez-Fernandez, I. A., Nazarian, R., Cheli, V. T., Chan, L. N., Malvar, J. S., de Vellis, J., Sabatti, C., & Dell'Angelica, E. C. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.58 · Cited by 145
Ikeda, Y., Yahata, N., Ito, I., Nagano, M., Toyota, T., Yoshikawa, T., Okubo, Y., & Suzuki, H. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.01.017 · Cited by 149
Romero, E., Ali, C., Molina‐Holgado, E., Castellano, B., Guaza, C., & Borrell, J. I. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301292 · Cited by 160
Addington, A. M., Gauthier, J., Piton, A., Hamdan, F. F., Raymond, A., Gogtay, N., Miller, R., Tossell, J. W., Bakalar, J. L., Germain, G., et al. (2010) · Molecular Psychiatry · doi:10.1038/mp.2010.59 · Cited by 164
Self-citationNyffeler, M., Meyer, U., Yee, B. K., Feldon, J., & Knuesel, I. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.07.029 · Cited by 139
The Complement System in Schizophrenia
(2008) · Drug News & Perspectives · doi:10.1358/dnp.2008.21.4.1213349 · Cited by 139
Childhood onset schizophrenia: support for a progressive neurodevelopmental disorder
Rapoport, J. L., & Gogtay, N. (2011) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2010.10.003 · Cited by 132
Self-citationMarco, E. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00063 · Cited by 136
“Despite CB2R was initially claimed as a peripheral cannabinoid receptor, its presence in CNS is still controversial [see A Brief Update on the Endocannabinoid (eCB) System].”
InfluentialPeng, W., Chen, Z., Yin, L., Jia, Z., & Gong, Q. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.04.001 · Cited by 136
Myelin, myelin-related disorders, and psychosis
Mighdoll, M. I., Tao, R., Kleinman, J. E., & Hyde, T. M. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2014.09.040 · Cited by 135
Peri-pubertal maturation after developmental disturbance: A model for psychosis onset in the rat
Pen, G. L., Gourévitch, R., Hazane, F., Hoareau, C., Jay, T. M., & Krebs, M. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.08.004 · Cited by 146
Torkamani, A., Dean, B., Schork, N. J., & Thomas, E. A. (2010) · Genome Research · doi:10.1101/gr.101956.109 · Cited by 134
“The neurodevelopmental model of schizophrenia posits that abnormalities during critical developmental periods increase the risk for the subsequent emergence of clinical symptoms (Marenco and Weinberger 2000; Rapoport et al. 2005).”
BackgroundRotarska-Jagiela, A., Oertel‐Knoechel, V., Martino, F. D., van de Ven, V. G., Formisano, E., Roebroeck, A. F., Rami, A., Schoenmeyer, R., Haenschel, C., Hendler, T., et al. (2009) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2009.03.002 · Cited by 147
Brain Neuroplasticity in Healthy, Hyperactive and Psychotic Children: Insights from Neuroimaging
Rapoport, J. L., & Gogtay, N. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301553 · Cited by 132
Self-citationWalterfang, M., Wood, S. J., Velakoulis, D., & Pantelis, C. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.02.001 · Cited by 138
Heritability of Changes in Brain Volume Over Time in Twin Pairs Discordant for Schizophrenia
Brans, R. G. H., van Haren, N. E. M., van Baal, G. C. M., Schnack, H. G., Kahn, R. S., & Pol, H. E. H. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.11.1259 · Cited by 129
Cerebral Asymmetry in Schizophrenia
Oertel-Knöchel, V., & Linden, D. E. J. (2011) · The Neuroscientist · doi:10.1177/1073858410386493 · Cited by 119
Neurobiology of Aggression and Violence in Schizophrenia
Soyka, M. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr103 · Cited by 123
Prenatal and postnatal maternal contributions in the infection model of schizophrenia
Meyer, U., Schwendener, S., Feldon, J., & Yee, B. K. (2006) · Experimental Brain Research · doi:10.1007/s00221-006-0419-5 · Cited by 147
“…delay between the immunological manipulation in utero and the onset of psychopathology in adulthood exists, and this is consistent with the developmental aetiology and disease process of schizophrenia and related disorders (Jakob and Beckman 1986; Weinberger 1987; Rapoport et al. 2005).”
BackgroundNeuropathology of schizophrenia: A mini review
Iritani, S. (2007) · Neuropathology · doi:10.1111/j.1440-1789.2007.00798.x · Cited by 136
Carter, C. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.05.023 · Cited by 139
Gogtay, N., Lu, A., Leow, A. D., Klunder, A. D., Lee, A. D., Chavez, A., Greenstein, D., Giedd, J. N., Toga, A. W., Rapoport, J. L., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806485105 · Cited by 125
Self-citationDevelopmental vulnerability of synapses and circuits associated with neuropsychiatric disorders
Penzes, P., Buonanno, A., Passafaro, M., Sala, C., & Sweet, R. A. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12261 · Cited by 125
Gogtay, N. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm103 · Cited by 124
“Candidate gene association studies and cytogenetic studies also show increased rates of abnormalities for the COS population, which are clearly higher than those seen for the AOS.(79) We are beginning to explore the influence of individual risk alleles on GM developmental trajectories.”
BackgroundNeurocognitive allied phenotypes for schizophrenia and bipolar disorder
Hill, S. K., Harris, M. S. H., Herbener, E. S., Pavuluri, M., & Sweeney, J. A. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn027 · Cited by 123
Kostović, I., Judaš, M., & Sedmak, G. (2011) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2010.09.005 · Cited by 121
Plaze, M., Paillere-Martinot, M.-L., Penttila, J., Januel, D., de Beaurepaire, R., Bellivier, F., Andoh, J., Galinowski, A., Gallarda, T., Artiges, E., et al. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp081 · Cited by 115
Adhesion G protein-coupled receptors in nervous system development and disease
Langenhan, T., Piao, X., & Monk, K. R. (2016) · Nature reviews. Neuroscience · doi:10.1038/nrn.2016.86 · Cited by 127
Feinberg, I., Higgins, L. M., Khaw, W. Y., & Campbell, I. G. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00293.2006 · Cited by 115
The medial pulvinar: function, origin and association with neurodevelopmental disorders
Homman‐Ludiye, J., & Bourne, J. A. (2019) · Journal of Anatomy · doi:10.1111/joa.12932 · Cited by 117
D’Souza, D. C., Pittman, B., Perry, E., & Simen, A. (2009) · Psychopharmacology · doi:10.1007/s00213-008-1333-2 · Cited by 117
“One view of schizophrenia is that it is a neurodevelopmental disorder (Rapoport et al. 2005; Weinberger 1996), and neurotrophic factors have been implicated in its pathophysiology (Buckley et al. 2007; Pillai 2008; Shoval and Weizman 2005).”
Berman, R. A., Gotts, S. J., McAdams, H. M., Greenstein, D. K., Lalonde, F. M., CLASEN, L. S., Watsky, R. E., Shora, L., Ordóñez, A. E., Raznahan, A., et al. (2015) · Brain · doi:10.1093/brain/awv306 · Cited by 119
“The first is that schizophrenia is a neurodevelopmental disorder, in which the overt clinical symptoms are preceded by alterations in brain development (Weinberger, 1987; Rapoport et al., 2005).”
BackgroundSelf-citationGray Matter Alterations in Schizophrenia High-Risk Youth and Early-Onset Schizophrenia
Brent, B. K., Thermenos, H. W., Keshavan, M. S., & Seidman, L. J. (2013) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2013.06.003 · Cited by 112
Developmental Differences Between Schizophrenia and Bipolar Disorder
Parellada, M., Gomez-Vallejo, S., Burdeus, M., & Arango, C. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx126 · Cited by 114
All Wrapped Up: Environmental Effects on Myelination
Forbes, T. A., & Gallo, V. (2017) · Trends in Neurosciences · doi:10.1016/j.tins.2017.06.009 · Cited by 101
Garibotto, V., Scifo, P., Gorini, A., Alonso, C. R., Brambati, S., Bellodi, L., & Perani, D. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.11.003 · Cited by 113
Evidence for disruption of sphingolipid metabolism in schizophrenia
Narayan, S., Head, S. R., Gilmartin, T. J., Dean, B., & Thomas, E. A. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.21822 · Cited by 113
“Dysfunctions in these systems have been implicated in the pathophysiology of schizophrenia (Thompson et al., 2004; Woo and Crowell, 2005; Rapoport et al., 2005; Nawa and Takei, 2006; Saetre et al., 2007), a devastating, Contract grant sponsor: National Institutes of Health; Contract grant number:…”
BackgroundBetcheva‐Krajcir, E., Mushiroda, T., Takahashi, A., Kubo, M., Karachanak-Yankova, S., Zaharieva, I. T., Vazharova, R., Dimova, I. I., Milanova, V. K., Tolev, T., et al. (2009) · Journal of Human Genetics · doi:10.1038/jhg.2008.14 · Cited by 124
Abnormal Cortical Growth in Schizophrenia Targets Normative Modules of Synchronized Development
Alexander-Bloch, A. F., Reiss, P. T., Rapoport, J., McAdams, H., Giedd, J. N., Bullmore, E. T., & Gogtay, N. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.02.010 · Cited by 110
Self-citationThorup, A. A. E., Jepsen, J. R. M., Ellersgaard, D., Burton, B. K., Christiani, C. J., Hemager, N., Skjærbæk, M., Ranning, A., Spang, K. S., Gantriis, D. L., et al. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0616-5 · Cited by 115
Burdick, K. E., Kamiya, A., Hodgkinson, C. A., Lencz, T., DeRosse, P., Ishizuka, K., Elashvili, S., Arai, H., Goldman, D., Sawa, A., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn146 · Cited by 110
Longitudinal Brain Changes in Early-Onset Psychosis
Arango, C., Moreno, C., Martinez, S., Parellada, M., Desco, M., Moreno, D., Fraguas, D., Gogtay, N., James, A., & Rapoport, J. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm157 · Cited by 108
Self-citationAddington, A. M., Gornick, M. C., Shaw, P., Seal, J., Gogtay, N., GREENSTEIN, D. K., CLASEN, L. S., Coffey, M., Gochman, P., Long, R. T. L., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001906 · Cited by 115
Self-citationHuang, W., Li, S., Hu, Y., Yu, H., Luo, F., Zhang, Q., & Zhu, F. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp166 · Cited by 115
Impact of Sex and Gonadal Steroids on Neonatal Brain Structure
Knickmeyer, R. C., Wang, J., Zhu, H., Geng, X., Woolson, S., Hamer, R. M., Konneker, T., Styner, M., & Gilmore, J. H. (2014) · Cerebral Cortex · doi:10.1093/cercor/bht125 · Cited by 109
“There is also extensive evidence that adult-onset diseases, such as schizophrenia, originate in early brain development (Rapoport et al. 2005; Fatemi and Folsom 2009).”
BackgroundTracing the development of psychosis and its prevention: what can be learned from animal models
Piontkewitz, Y., Arad, M., & Weiner, I. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.04.019 · Cited by 108
“…and Folsom, 2009; Harrison, 1999, 2004; Harrison and Weinberger, 2005; Keshavan, 1999; Keshavan and Hogarty, 1999; Lewis and Levitt, 2002; McGlashan and Hoffman, 2000; Meyer and Feldon, 2010; Pantelis et al., 2003; Rapoport et al., 2005; Weinberger, 1987; Weinberger and McClure, 2002; Woods, 1998).”
InfluentialGenetic Mouse Models of Schizophrenia: From Hypothesis-Based To Susceptibility Gene-Based Models
Chen, J., Lipska, B. K., & Weinberger, D. R. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.024 · Cited by 115
Transcranial direct current stimulation in children and adolescents: a comprehensive review
Palm, U., Segmiller, F. M., Epple, A. N., Freisleder, F. J., Koutsouleris, N., Schulte‐Körne, G., & Padberg, F. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1572-z · Cited by 112
Interaction between FEZ1 and DISC1 in Regulation of Neuronal Development and Risk for Schizophrenia
Kang, E., Burdick, K. E., Kim, J. Y., Duan, X., Guo, J. U., Sailor, K. A., Jung, D.-E., Ganesan, S., Choi, S., Pradhan, D. A., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.032 · Cited by 118
Haas, M., Eerdekens, M., Kushner, S. F., Singer, J., Augustyns, I., Quiroz, J. A., Pandina, G., & Kusumakar, V. (2009) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.107.046177 · Cited by 103
Biological hypotheses, risk factors, and biomarkers of schizophrenia
Fišar, Z. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110626 · Cited by 112
Meyer, U., & Feldon, J. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1504-9 · Cited by 119
Analysis of induced pluripotent stem cells carrying 22q11.2 deletion
Toyoshima, M., Akamatsu, W., Okada, Y., Ohnishi, T., Balan, S., Hisano, Y., Iwayama, Y., Toyota, T., Matsumoto, T., Itasaka, N., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.206 · Cited by 112
Does the dopamine hypothesis explain schizophrenia?
Lau, C. I., Wang, H.-C., Hsu, J.-L., & Liu, M. (2013) · Reviews in the Neurosciences · doi:10.1515/revneuro-2013-0011 · Cited by 134
Wedenoja, J., Loukola, A., Tuulio‐Henriksson, A., Paunio, T., Ekelund, J., Silander, K., Varilo, T., Heikkila, K. V., Suvisaari, J., Partonen, T., et al. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002047 · Cited by 114
The Genetics of Symptom-Based Phenotypes: Toward a Molecular Classification of Schizophrenia
DeRosse, P., Lencz, T., Burdick, K. E., Siris, S. G., Kane, J. M., & Malhotra, A. K. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn076 · Cited by 94
Solomon, M., Olsen, E., Niendam, T., Ragland, J. D., Yoon, J., Minzenberg, M., & Carter, C. S. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.03.005 · Cited by 99
“…idea that autism and schizophrenia are discrete syndromes, however, is somewhat at odds with the prominent “neurodevelopmental” view of schizophrenia (Rapoport et al., 2005), which proposes that schizophrenia specific brain abnormalities are present in early life (or even in utero), even though…”
Treating the placenta to prevent adverse effects of gestational hypoxia on fetal brain development
Phillips, T. J., Scott, H., Menassa, D. A., Bignell, A. L., Sood, A., Morton, J. S., Akagi, T., Azuma, K., Rogers, M. F., Gilmore, C. E., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06300-1 · Cited by 99
Möller, H. (2008) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-008-2004-3 · Cited by 108
Neurodevelopmental Disorders: Conceptual Issues
Bishop, D., & Rutter, M. (2008) · Rutter's Child and Adolescent Psychiatry · doi:10.1002/9781444300895.ch3 · Cited by 87
Sex and schizophrenia: a review of gender differences
Falkenburg, J., & Tracy, D. K. (2012) · Psychosis · doi:10.1080/17522439.2012.733405 · Cited by 112
Abnormalities in structural covariance of cortical gyrification in schizophrenia
Palaniyappan, L. K., Park, B., Balain, V., Dangi, R., & Liddle, P. F. (2014) · Brain Structure and Function · doi:10.1007/s00429-014-0772-2 · Cited by 99
Role of DISC1 in neural development and schizophrenia
Mackie, S., Millar, J. K., & Porteous, D. J. (2007) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2007.01.007 · Cited by 101
Cortex Morphology in First-Episode Psychosis Patients With Neurological Soft Signs
Gay, O., Plaze, M., Oppenheim, C., Mouchet-Mages, S., Gaillard, R., Olié, J., Krebs, M., & Cachia, A. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs083 · Cited by 93
Metabotropic glutamate receptor 5 in the pathology and treatment of schizophrenia
Matosin, N., & Newell, K. A. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.12.005 · Cited by 101
“As schizophrenia is classified as a neurodevelopmental disorder (Rapoport et al., 2005), it is important to characterise these agents’ potential during critical neurodevelopmental phases such as adolescence.”
BackgroundThe genetics of childhood-onset schizophrenia: When madness strikes the prepubescent
Addington, A. M., & Rapoport, J. L. (2009) · Current Psychiatry Reports · doi:10.1007/s11920-009-0024-y · Cited by 90
Self-citationPositive symptoms and white matter microstructure in never-medicated first episode schizophrenia
Cheung, V., Chiu, C. P. Y., Law, C. W., Cheung, C., Hui, C. L. M., Chan, K. K. S., Sham, P. C., Deng, M. Y., Tai, K. S., Khong, P.-L., et al. (2011) · Psychological Medicine · doi:10.1017/s003329171000156x · Cited by 93
“Since schizophrenia can be regarded as a disorder of neurodevelopment (Bullmore et al. 1997 ; Rapoport et al. 2005), DTI presents a safe and convenient tool to study how brain connectivity in patients differs from healthy individuals.”
BackgroundNeuregulin signaling, cortical circuitry development and schizophrenia
Rico, B., & Marín, Ó. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.12.010 · Cited by 105
Progesterone: The neglected hormone in schizophrenia? A focus on progesterone-dopamine interactions
Sun, J., Walker, A. J., Dean, B., van den Buuse, M., & Gogos, A. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.08.019 · Cited by 99
Epigenetic changes at gene promoters in response to immune activation in utero
Tang, B., Jia, H., Kast, R. J., & Thomas, E. A. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.01.086 · Cited by 91
Proteome analysis of schizophrenia brain tissue
Martins-De-Souza, D., Dias-Neto, E., Schmitt, A., Falkai, P., Gormanns, P., Maccarrone, G., Turck, C. W., & Gattaz, W. F. (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622970903490626 · Cited by 89
“These processes are thought to belong to the core of the biology of SCZ; clinical and experimental evidence strongly suggest that SCZ may be seen as a disorder of brain development in infancy and adolescence resulting in a brain dysfunction that underlies the onset of cognitive and psychopathological symptoms in early…”
BackgroundWood, J. D., Bonath, F., Kumar, S., Ross, C. A., & Cunliffe, V. T. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddn361 · Cited by 90
Reelin-mediated signaling in neuropsychiatric and neurodegenerative diseases
Knuesel, I. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.002 · Cited by 89
“…origin, in which an initial, triggering event results in a robust set of neuroadaptations that significantly and progressively derange normal brain function, potentially long before the illness is clinically manifest (Weinberger, 1987; Harrison, 1997; Rapoport et al., 2005; Sun et al., 2009).”
Hemager, N., Plessen, K. J., Thorup, A. A. E., Christiani, C. J., Ellersgaard, D., Spang, K. S., Burton, B. K., Gregersen, M., Søndergaard, A., Greve, A. N., et al. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.1415 · Cited by 98
Brain structure and function correlates of cognitive subtypes in schizophrenia
Geisler, D., Walton, E., Naylor, M., Roessner, V., Lim, K. O., Schulz, S. C., Gollub, R. L., Calhoun, V. D., Sponheim, S. R., & Ehrlich, S. (2015) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2015.08.008 · Cited by 94
“Due to the putative pathogenetic neurodevelopmental mechanisms proposed to underlie schizophrenia (Weinberger, 1987; Rapoport et al., 2005) cortical thickness may be of even greater etiologic relevance than grey matter volume or density.”
One-carbon metabolism and schizophrenia: current challenges and future directions
Krebs, M., Bellon, A., Mainguy, G., Jay, T. M., & Frieling, H. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.10.001 · Cited by 92
Trzesniak, C. M. F., de Oliveira, I. R., Kempton, M. J., Almeida, A. G.-D., Chagas, M. H. N., Ferrari, M. C. F., Filho, A. S., Zuardi, A. W., Prado, D. A., Busatto, G. F., et al. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.09.016 · Cited by 89
Dysbindin-1, WAVE2 and Abi-1 form a complex that regulates dendritic spine formation
Ito, H., Morishita, R., Shinoda, T., Iwamoto, I., Sudo, K., Okamoto, K., & Nagata, K. (2010) · Molecular Psychiatry · doi:10.1038/mp.2010.69 · Cited by 88
Hu, M., Li, J., Eyler, L. T., Guo, X., Wei, Q., Tang, J., Liu, F., He, Z., Li, L., Jin, H., et al. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2012.12.018 · Cited by 91
Models of Neurodevelopmental Abnormalities in Schizophrenia
Powell, S. B. (2010) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2010_57 · Cited by 84
Höistad, M. (2009) · Frontiers in Neuroanatomy · doi:10.3389/neuro.05.009.2009 · Cited by 86
“…found decreased oligodendrocyte densities in cingulate area 24 but not in the adjacent paracingulate area 32, and Hof et al. (2003) found 2002; Rapoport et al., 2005; Weinberger, 1986, 1987) and altered neuronal circuitry (Selemon and Goldman-Rakic, 1999), particularly in the prefrontal…”
Genomic imprinting in the development and evolution of psychotic spectrum conditions
Crespi, B. (2008) · Biological Reviews · doi:10.1111/j.1469-185x.2008.00050.x · Cited by 86
“Like the autistic spectrum, conditions on the psychotic spectrum exhibit strong genetic components to their expression, but with many genes involved and different combinations of these genes capable of contributing to the phenotypes (Rapoport et al., 2005; Tamminga & Holcomb, 2005).”
BackgroundMethodInfluentialLempel–Ziv complexity in schizophrenia: A MEG study
Fernández, A., López‐Ibor, M., Turrero, A., Santos, J.-M., Morón, M.-D., Hornero, R., Gómez, C., Méndez, M. A., Ortiz, T., & López-Ibor, J. J. (2011) · Clinical Neurophysiology · doi:10.1016/j.clinph.2011.04.011 · Cited by 101
“…neurodegenerative perspective has been challenged by the so-called neurodevelopmental theory (Murray and Lewis, 1987; Rapoport et al., 2005) which considers SCH as the product of a deviation in neurodevelopmental processes that occurs before the onset of clinical symptoms (Rapoport et al., 2005).”
Woods, R. M., Lorusso, J. M., Fletcher, J., ElTaher, H., McEwan, F., Harris, I., Kowash, H. M., D'Souza, S. W., Harte, M., Hager, R., et al. (2023) · Neuronal Signaling · doi:10.1042/ns20220064 · Cited by 96
Zalesky, A., Pantelis, C., Cropley, V., Fornito, A., Cocchi, L., McAdams, H. M., CLASEN, L. S., GREENSTEIN, D. K., Rapoport, J. L., & Gogtay, N. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.0226 · Cited by 90
Self-citationAnderson, G., Maes, M. H. J., & Berk, M. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.07.016 · Cited by 100
“However, anti‐inflammatory treatments do not have superior effects in schizophrenic patients with longstanding disease (Meyer, 2013–this issue; Rapoport et al., 2005).”
BackgroundLongitudinal progression of frontal and temporal lobe changes in schizophrenia
Cobia, D. J., Smith, M. J., Wang, L., & Csernansky, J. G. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.05.002 · Cited by 94
“Our findings also inform current theories that the pathogenesis of schizophrenia includes a progressive component, which may be influenced by genetic and environmental factors throughout the course of the disease (Harrison & Weinberger, 2005; Rapoport et al., 2005).”
BackgroundVenkatasubramanian, G., Chittiprol, S., Neelakantachar, N., Shetty, T., & Gangadhar, B. N. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.01.033 · Cited by 91
Alterations of dopamine and serotonin transmission in schizophrenia
Remington, G. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00906-0 · Cited by 96
Ryu, V., Yoo, S. B., Kang, D. W., Lee, J.-H., & Jahng, J. W. (2009) · Brain Research · doi:10.1016/j.brainres.2009.08.006 · Cited by 93
Mehl, S., Rief, W., Mink, K., Lüllmann, E., & Lincoln, T. M. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.10.004 · Cited by 95
Regional Gray Matter Volume Deficits in Adolescents With First-Episode Psychosis
Janssen, J., Reig, S., Parellada, M., Moreno, D. M., Graell, M., Fraguas, D., Zabala, A., Vazquez, V. G., Desco, M., & Arango, C. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318184ff48 · Cited by 91
Greenstein, D., Malley, J. D., Weisinger, B., Clasen, L., & Gogtay, N. (2012) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2012.00053 · Cited by 75
Oudin, M. J., Hobbs, C., & Doherty, P. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07831.x · Cited by 82
Cognitive function in early onset schizophrenia: a selective review
Frangou, S. (2009) · Frontiers in Human Neuroscience · doi:10.3389/neuro.09.079.2009 · Cited by 78
“In its simplest form this model posits that schizophrenia is the behavioural outcome of aberrant neurodevelopment that begins long before the onset of clinical symptoms and is caused by a combination of environmental and genetic factors (Rapoport et al., 2005).”
Self-citationSeverinsen, J. E., Bjarkam, C. R., Kiar-Larsen, S., Olsen, I. M. L., Nielsen, M. M., Blechingberg, J., Nielsen, A. L., Holm, I. E., Foldager, L., Young, B. D., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001885 · Cited by 90
Sex-dependent and region-specific changes in TrkB signaling in BDNF heterozygous mice
Hill, R., & van den Buuse, M. (2011) · Brain Research · doi:10.1016/j.brainres.2011.01.060 · Cited by 85
Neurodevelopment and inflammatory patterns in schizophrenia in relation to pathophysiology
Altamura, A. C., Pozzoli, S. M., Fiorentini, A., & Dell’Osso, B. M. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.08.015 · Cited by 95
“…simplest form, postulates that the disorder could be the correlate of an aberration in neurodevelopmental process starting much earlier than the onset of clinical symptoms, caused by a combination of genetic and environmental factors (Cardno et al., 1999; Rapoport et al., 2005;Singh et al., 2004).”
Background
Metadata
- Authors
- Rapoport, J. L., Addington, A. M., Frangou, S., & Psych, M. R. C.
- Affiliations
- National Institutes of Health (US)
- King's College London (GB)
- Corresponding author
- Rapoport, J L
- Venue
- Molecular Psychiatry
- Published
- 2005-02-08
- Volume
- 10
- Issue
- 5
- Pages
- 434-449
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W2009995715
- Cited by
- 993
- References
- 180
- Citations by year
- 2026: 5 · 2025: 12 · 2024: 13 · 2023: 16 · 2022: 31 · 2021: 21 · 2020: 31 · 2019: 40 · 2018: 29 · 2017: 46 · 2016: 36 · 2015: 61 · 2014: 69 · 2013: 72 · 2012: 89
- FWCI
- 7.77
- Type
- journal article
- Language
- en
- Update notices
- erratum (2005-05-26)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Keywords
- schizophrenia, neurodevelopmental model, gray matter loss, early-onset schizophrenia, schizophrenia risk genes, 22q11.2 deletion syndrome, dysbindin, prenatal infection, gene-environment interaction, brain development, age of onset, heritability
- MeSH terms
- Adult, Brain, Child, Female, Humans, Infant, Models, Neurological, Models, Psychological, Pregnancy, Pregnancy Complications, Prenatal Exposure Delayed Effects, Risk Factors, Schizophrenia, Schizophrenic Psychology, Gene Expression Regulation, Developmental, Genetic Predisposition to Disease, Preconception Injuries
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.